Preprint Review Version 1 This version is not peer-reviewed

The Microbiota-Gut-Brain Axis: Key Mechanisms Driving Glymphopathy and Cerebral Small Vessel Disease

Version 1 : Received: 4 November 2024 / Approved: 4 November 2024 / Online: 5 November 2024 (11:15:15 CET)

How to cite: Che Mohd Nassir, C. M. N.; Che Ramli, M. D.; Mohamad Ghazali, M.; Jaffer, U.; Abdul Hamid, H.; Mehat, M. Z.; Hein, Z. M. The Microbiota-Gut-Brain Axis: Key Mechanisms Driving Glymphopathy and Cerebral Small Vessel Disease. Preprints 2024, 2024110255. https://doi.org/10.20944/preprints202411.0255.v1 Che Mohd Nassir, C. M. N.; Che Ramli, M. D.; Mohamad Ghazali, M.; Jaffer, U.; Abdul Hamid, H.; Mehat, M. Z.; Hein, Z. M. The Microbiota-Gut-Brain Axis: Key Mechanisms Driving Glymphopathy and Cerebral Small Vessel Disease. Preprints 2024, 2024110255. https://doi.org/10.20944/preprints202411.0255.v1

Abstract

The human microbiota constitutes a very complex ecosystem of microorganisms inhabiting both the inside and outside of our bodies, in which health maintenance and disease modification are the main regulatory features. The recent explosion of microbiome research has begun to detail its important role in neurological health, particularly concerning cerebral small vessel disease (CSVD), a disorder associated with cognitive decline and vascular dementia. This narrative review represents state-of-the-art knowledge of the intimate, complex interplay between microbiota and brain health through the gut-brain axis (GBA) and the emerging role of the glymphatic system dysfunction (glymphopathy) and circulating cell-derived microparticles (MPs) as mediators of these interactions. We discuss how microbial dysbiosis promotes neuroinflammation, vascular dysfunction, and impaired waste clearance in the brain which are critical factors in the pathogenesis of CSVD. Further, we discuss lifestyle factors that shape the microbiota composition and functionality, focusing on sleep as a modifiable risk factor in neurological disorders. This narrative review places recent microbiome research into a neuroscientific and vascular perspective to establish future therapeutic avenues in targeting the microbiota to improve brain health and reduce the burden of CSVD.

Keywords

Microbiota; gut-brain axis; microparticles; cerebral small vessel disease; sleep; glymphatic system

Subject

Biology and Life Sciences, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.